Barrington Research Reaffirms Outperform Rating for OPKO Health (NASDAQ:OPK)
Barrington Research reiterated their outperform rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a research report released on Friday morning, Benzinga reports. Barrington Research currently has a $2.25 price objective on the biotechnology company’s stock. A number of other brokerages also recently commented on OPK. HC Wainwright reissued a buy rating and […]
More Stories
Mercer International Inc. (MERC) To Go Ex-Dividend on September 25th
Mercer International Inc. (NASDAQ:MERC – Get Free Report) (TSE:MRI.U) declared a quarterly dividend on Thursday, August 8th, Zacks reports. Stockholders...
Canadian Apartment Properties Real Estate Investment Trust (OTCMKTS:CDPYF) Increases Dividend to $0.09 Per Share
Canadian Apartment Properties Real Estate Investment Trust (OTCMKTS:CDPYF – Get Free Report) announced a dividend on Saturday, September 21st, investing.com...
PHX Energy Services Corp. (PHXHF) To Go Ex-Dividend on September 27th
PHX Energy Services Corp. (OTCMKTS:PHXHF – Get Free Report) declared a dividend on Saturday, September 21st, investing.com reports. Investors of...
National Bank of Canada (NTIOF) to Issue Dividend of $0.81 on November 1st
National Bank of Canada (OTCMKTS:NTIOF – Get Free Report) declared a dividend on Saturday, September 21st, investing.com reports. Stockholders of...
Western Energy Services Corp. (TSE:WRG) Insider Sime Armoyan Purchases 5,800 Shares
Western Energy Services Corp. (TSE:WRG – Get Free Report) insider Sime Armoyan purchased 5,800 shares of the business’s stock in...
FedEx (NYSE:FDX) PT Lowered to $311.00 at UBS Group
FedEx (NYSE:FDX – Free Report) had its price objective trimmed by UBS Group from $333.00 to $311.00 in a report...